Allspring Global Investments Holdings, LLC Tarsus Pharmaceuticals, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $62.1 Billion
- Q3 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 210,531 shares of TARS stock, worth $11.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
210,531
Previous 181,066
16.27%
Holding current value
$11.7 Million
Previous $4.92 Million
40.7%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding TARS
# of Institutions
170Shares Held
43.3MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$189 Million1.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$181 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$135 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$125 Million6.32% of portfolio
-
Morgan Stanley New York, NY2.21MShares$122 Million0.01% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.48B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...